Source:http://linkedlifedata.com/resource/pubmed/id/19132323
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-2-19
|
pubmed:abstractText |
FasL plays a central role in the induction of apoptosis within the immune system. It mediates activation-induced cell death (AICD) of T lymphocytes and contributes to the cytotoxic effector function of T and NK cells. Moreover, FasL is discussed as direct effector molecule for the establishment of immune privilege and tumour survival. Besides its death-promoting activity, FasL has been implicated in reverse signalling and might thus also play a role in T cell development and selection and the modulation of T cell activation. Considering these diverse functions, the overall FasL expression has to be tightly controlled to avoid unwanted damage. Based on an activation-associated transcriptional control, several post-transcriptional processes ensure a safe storage, a rapid mobilisation, a target-directed activity and a subsequent inactivation. Over the past years, the identification and characterisation of FasL-interacting proteins provided novel insight into the mechanisms of FasL transport, processing and reverse signalling, which might be exemplary also for the other members of the TNF family.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0080-1844
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-61
|
pubmed:meshHeading |
pubmed-meshheading:19132323-Animals,
pubmed-meshheading:19132323-Cell Death,
pubmed-meshheading:19132323-Cell Survival,
pubmed-meshheading:19132323-Fas Ligand Protein,
pubmed-meshheading:19132323-Gene Expression Regulation,
pubmed-meshheading:19132323-Humans,
pubmed-meshheading:19132323-Killer Cells, Natural,
pubmed-meshheading:19132323-Lymphocyte Activation,
pubmed-meshheading:19132323-Neoplasms,
pubmed-meshheading:19132323-Signal Transduction,
pubmed-meshheading:19132323-T-Lymphocytes
|
pubmed:year |
2009
|
pubmed:articleTitle |
FasL expression and reverse signalling.
|
pubmed:affiliation |
Institute of Immunology, University Hospital Schleswig-Holstein Campus Kiel, Michaelisstr. 5, D-24105 Kiel, Germany.
|
pubmed:publicationType |
Journal Article,
Review
|